Stay updated on Sacituzumab Govitecan in Metastatic Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Sacituzumab Govitecan in Metastatic Solid Tumors Clinical Trial page.

Latest updates to the Sacituzumab Govitecan in Metastatic Solid Tumors Clinical Trial page
- Check2 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing the previous Revision: v3.6.2, indicating a new revision of the study record.SummaryDifference0.0%

- Check9 days agoChange DetectedThe page now displays Revision: v3.6.2, replacing the previous Revision: v3.6.0. This appears to be a frontend version update and does not change the study details, enrollment, or results on the page.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe study page shows recruitment status updated to not recruiting and adds new guidance sections for reading the study record, joining the study, and frequently asked questions. It also includes a formatting change for the Interventions heading and updates the revision version from v3.5.5 to v3.6.0.SummaryDifference0.3%

- Check31 days agoChange DetectedRevision: v3.5.5 has been added, replacing the previous v3.5.4 entry. This reflects a new page revision being published.SummaryDifference0.0%

- Check52 days agoChange DetectedPage revision updated from v3.5.3 to v3.5.4, indicating deployment of a newer page version. This is an administrative update and does not modify study content or results.SummaryDifference0.0%

- Check59 days agoChange DetectedThe Taiwan site entry is updated from Taoyuan, Taiwan, 33305 to Taoyuan City, Taiwan, 33305. This clarifies the exact city designation for the site and helps participants locate the correct venue.SummaryDifference0.0%

Stay in the know with updates to Sacituzumab Govitecan in Metastatic Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sacituzumab Govitecan in Metastatic Solid Tumors Clinical Trial page.